Interaction of bacteriophage lambda with its cell surface receptor: an in vitro study of binding of the viral tail protein gpJ to LamB (Maltoporin).
The cell surface receptor for bacteriophage Lambda is LamB (maltoporin). Responsible for phage binding to LamB is the C-terminal part, gpJ, of phage tail protein J. To study the interaction between LamB and gpJ, a chimera protein composed of maltose binding protein (MBP or MalE) connected to the C-terminal part of J (gpJ, amino acids 684-1131) of phage tail protein J of bacteriophage Lambda was expressed in Escherichia coli and purified to homogeneity. The interaction of the MBP-gpJ chimera protein with reconstituted LamB and its mutants LamB Y118G and the loop deletion mutant LamB Delta4+Delta6+Delta9v was studied using planar lipid bilayer membranes on a single-channel and multichannel level. Titration with the MBP-gpJ chimera blocked completely the ion current through reconstituted LamB when it was added to the cis side, the extracellular side of LamB with a half-saturation constant of approximately 6 nM in 1 M KCl. Control experiments with LamB Delta4+Delta6+Delta9v from which all major external loops had been removed showed similar blocking, whereas MBP alone caused no visible effect. Direct conductance measurement with His(6)-gpJ that contained a hexahistidyl tag (His(6) tag) at the N-terminal end of the protein for easy purification revealed no blocking of the ion current, requiring other measurements for the binding constant. However, when maltoporin was preincubated with His-gpJ, MBP-gpJ could not block the channel, which indicated that also His(6)-gpJ bound to the channel. High-molecular mass bands on SDS-PAGE and Western blots, confirming the planar lipid bilayer experiment results, also demonstrated stable complex formation between His(6)-gpJ and LamB or LamB mutants. The results revealed that phage Lambda binding includes not only the extracellular loops.
Lehrstuhl für Biotechnologie, Biocenter of the University of Würzburg, Am Hubland, D-97074 Würzburg, Federal Republic of Germany.
Emir
E
Berkane
Frank
F
Orlik
Johannes F
JF
Stegmeier
Alain
A
Charbit
Mathias
M
Winterhalter
Roland
R
Benz
D001425:Bacterial Outer Membrane Proteins; D010582:Bacteriophage lambda / Q000378:metabolism*; D015153:Blotting, Western; D002352:Carrier Proteins / Q000378:metabolism; D004492:Edetic Acid / Q000378:metabolism / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D004795:Enzyme Stability; D017353:Gene Deletion; D006639:Histidine / Q000378:metabolism; D017136:Ion Transport / Q000187:drug effects; D008274:Magnesium / Q000378:metabolism / Q000494:pharmacology; D058619:Maltose-Binding Proteins; D009154:Mutation; D009844:Oligosaccharides / Q000378:metabolism; D018272:Porins; D011485:Protein Binding; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011991:Receptors, Virus / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D017376:Viral Tail Proteins / Q000378:metabolism*
D001425:Bacterial Outer Membrane Proteins; D002352:Carrier Proteins; C083033:J protein, Bacteriophage lambda; D058619:Maltose-Binding Proteins; D009844:Oligosaccharides; D018272:Porins; D011956:Receptors, Cell Surface; D011991:Receptors, Virus; D011993:Recombinant Fusion Proteins; D017376:Viral Tail Proteins; C016532:maltoporins; C019193:maltopentaose; D006639:Histidine; D004492:Edetic Acid; D008274:Magnesium